Pain in the Access
Subscribe
Sign in
Home
Archive
MFN and the Warped Curve
The uneven consequences of most-favored-nations (MFN) pricing
Sep 25
•
John Jarvis
Pharma's Bundle Strategy
Molecule + Bundle = Pharma’s New Moat
Sep 21
•
John Jarvis
PBMs and the App Store
Apple taxes apps. PBMs tax drugs. Lessons from the App Store for pharma
Sep 11
•
John Jarvis
1
Welcome to Pain in the Access
Connecting value, access, and evidence to business strategy in pharma
Sep 9
•
John Jarvis
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts